Journal of Vascular and Interventional Radiology
New JVIR website now provides easy member access
JVIR’s newly redesigned website was successfully launched on March 16. Displaying a clean design, the user-friendly website offers easy access and navigation, and delivers enhanced search capabilities.
With their SIR username and password, members benefit from seamless access to the website content and features (no need to remember two passwords).
To sign in, login with your SIR login name and password at the SIR Member Login links, and just follow the prompts. There will be a one-time prompt to connect an SIR username to an jvir.org user profile as follows:
- An Existing Account Found notification for SIR members who HAVE previously registered a username for jvir.org on Elsevier’s platfor).
- A one-time Register your SIR Member Login prompt for SIR members who HAVE NOT previously registered a username for jvir.org on Elsevier’s platform.
Trouble signing in?
- For assistance with SIR user name and password issues, contact Membership@SIRweb.org for questions.
- For questions about using or accessing the website or mobile apps, contact Elsevier’s support team:
Tel: (800) 654-2452 (Toll Free US & Canada)
Tel: (314) 447-8871 (Outside US & Canada)
Visit us, and stay tuned—more to follow soon.
You can now take JVIR on the go. Click here for access instructions to upgrade today. With the new version (free, with a journal subscription), you can:
- Browse new issues and read new articles in press throughout the month, or jump to the featured articles with just a tap.
- Download issues while reading: no more waiting.
- Get the content you want more quickly and conveniently thanks to layouts and navigation.
- Interact with figures, tables, multimedia and supplementary content with updated in-article navigation.
- Personalize your experience with features such as My Reading List, Notes, saved articles for offline reading, sharing articles via social media and emailing useful content.
From the JVIR editor, Ziv J Haskal
September JVIR is All in for IO. I bring you the annual Interventional Oncology issue—a dense volume of nearly 200 pages of important work with perspectives on what we’ve done, what we do, and what we might well be doing. Plan on delving in with time at hand—there's too much to skim in one or two sittings.
Among the topics: An expert review of chemoembolization, comparison of single vs. triple-drug TACE, models of assessing TACE outcomes in select populations, conventional vs. drug-eluting embolics for neuroendocrine tumors, radioembolization in breast cancer metastases (results, imaging and commentary), controlled study of cone beam CT guided biopsy, microwave radiofrequency and cryoablation of lung tumors, caval stents in malignant obstruction, renal tumor electroporation and thermal ablation, vertebroplasty of blastic painful metastases, labs studies , letters and more.
Get highlights at JVIRAccess.org, join 10,000 at @JVIRMedia, grab a podcast and more.
Note our new suggestion box on jvir.org. I welcome your ideas, author queries, presubmission questions, volunteers, whatever comes to mind.
Finally, Extreme IR is back, in 2017 in Washington, D.C. The smashing success of the half-day Extreme IR/Extreme M&M session returns to the SIR Annual Scientific Meeting in Washington in 2017. Last year we had approximately 27 faculty, from trainees to renowned experts, sharing approximately 50 cases. This year, we further strengthen the tie-in with JVIR (and the possibility of publishing your extreme cases in JVIR). We are opening some podium slots for your submitted cases from around the world—be you a trainee or wise beyond years.
Send a brief description of your 6-minute case to email@example.com to potentially be chosen to present your Extreme IR case at the SIR Annual Scientific Meeting.
2015—Biggest year yet for JVIR submissions!
We've had another shatteringly good year, with a record-breaking number of submissions, exceeding 1,200 in 2015. It's an astounding climb considering that as recently as 2013 we were celebrating the milestone of 1,000 submissions. Despite these increases, we've maintained our average time to first decision on new manuscripts at 26 days in 2015.
JVIR builds its strength on your cutting-edge research. Your interventional and endovascular work can change lives in ways today and provide the base for future research like no other medical discipline. I encourage you to submit your manuscript to JVIR, and keep your eyes on us for a number of innovations and new features this year.
JVIR wishes you a successful and prosperous new year!
Ziv J Haskal
About the Journal of Vascular and Interventional Radiology
The Journal of Vascular and Interventional Radiology (JVIR) is the official scientific journal of the Society of Interventional Radiology. For two decades, this peer-reviewed journal has been the preferred reference choice of interventional radiologists, radiologists, cardiologists, vascular surgeons, neurosurgeons and other clinicians who need current and reliable information on every aspect of vascular and interventional radiology.
Each issue of JVIR covers the most critical and cutting-edge medical, minimally-invasive, radiological, pathological and socioeconomic issues of importance to vascular and interventional radiologists. JVIR brings more than 5,000 readers monthly clinical studies, laboratory investigations, brief scientific reports, continuing education articles and employment opportunities.
JVIR = Impact for science: Learn more from editor Ziv Haskal on The Vision to Heal blog
The Journal of Vascular and Interventional Radiology's impact factor is but one single, partial metric that captures one aspect of an academic journal's universe. What else do you need to know about SIR's monthly, peer-reviewed flagship publication?
JVIR impact factor increases 12 percent, ranks highest of IR journals
The Journal of Vascular and Interventional Radiology’s impact factor—one measure of a publication’s impact or significance based on the number of article citations compared to the total number of articles published—increased 12 percent in 2014. This success mirrors the journal’s publication of “impactful” research, says Editor-in-Chief Ziv J Haskal, MD, FSIR. Equally important, is the doubling of new journal manuscript submissions in the past three years. Read more from Dr. Haskal in “The vision to heal” blog. SIR will also be distributing a related press release. Please send your congratulations to Dr. Haskal and members of the JVIR editorial board.
25 years of innovation exhibit now online
Exhibit JVIR Celebrates 25 Years of Innovation from the 2015 SIR Annual Meeting now online.
New Resource for JVIR Content: The News You Need
The Journal of Vascular and Interventional Radiology has unveiled a new source for the latest news and information you need: JVIR Access. Website content is directed to JVIR readers at all levels and is posted on the first of each month.
Selected monthly summaries and commentaries highlight important articles from the most recent issue of JVIR, place them into larger perspective and indicate how they may affect your daily practice. Recent posts include:
- Covered vs. uncovered stents for malignant common bile duct obstruction, which lasts longer?
- New study examines the effectiveness of collateral vein embolization for non-maturing fistulas.
- Preoperative embolization in surgical treatment of spinal metastases shows no improvement in intraoperative blood loss.
Since its inauguration last fall, JVIR Access has already logged tens of thousands of views. Follow @JVIRmedia on Twitter and Instagram for notifications of the most recent postings. If you are interested in joining JVIR Access staff, please email your CV and cover letter to JVIRAccess@gmail.com.
From the Editor: JVIR Beacon
The Journal of Vascular and Interventional Radiology announces, JVIR Beacon, a new pilot program intended to help disseminate IR knowledge and education to interventional physicians in areas of the world with limited resources and access to IR science. JVIR and SIR are committed to advancing healthcare in the developing lower-income countries. We wish to support IR education, clinical practice and volunteerism in such environments to help build local IR programs and train experts.
To this end, we have made available a limited number of free electronic 1-year online subscriptions to JVIR for qualified practitioners in third-world, lower-income countries.
I encourage interested individuals to write directly to JVIR at: JVIRBeacon@gmail.com.Tell us about your individual circumstances as a potential candidate for the subscription.
We also wish to make readers aware of the World Health Organization (WHO) program to bring biomedical and health literature access to tens of thousands of journals and e-books through the HINARI program: http://www.who.int/hinari/en/.
Please spread the word to your colleagues, contacts and any potentially interested parties.
Podcasts from JVIR
Visit JVIR's podcasts on the JVIR home page or the podcast page under the Multimedia tab to listen to Dr. Timothy McClure discussing his recent article on the efficacy of radiofrequency ablation of renal cell carcinoma and Dr. Hristina Natcheva discussing her recent article on physician opinion regarding ancillary staffing for the IR suite.
News for JVIR authors: Extreme IR
JVIR is soliciting “extreme IR” submissions—articles focused on resolving unexpected clinical problems with innovative solutions, dealing with unanticipated procedural dilemmas, responding to unusual clinical needs, or creating entirely new branches of therapy. For details on this new article type, check the “Extreme IR” entry in JVIR’s Instructions for Authors.
JVIR Editorial Board
Meet the JVIR Editorial Board.
JVIR Ablation-focused Resource
At JVIR's ablation-focused website resource, you can sign up for notifications of upcoming new content, including interactive blogs and case discussions moderated by renowned experts, reader comments, video webinars (potential additions), podcast links and author-narrated slides for ablation-related papers.
JVIR’s current vodcast features SIR member, Michael Beheshti, M.D. and SIR Fellow-in-training Amish Patel discussing operating expenses for conventional transcatheter arterial embolization (TACE).
Week of November 17
Intermediate Outcomes and Predictors of Efficacy in the Radiofrequency Ablation of 100 Pathologically Proven Renal Cell Carcinomas
Timothy McClure, M.D., of The Ohio State University (Columbus) discusses his recent article with SIR Resident-in-training Kyle Cooper, JVIR media correspondent. Follow us on Twitter @JVIRMedia
Intermediate Outcomes and Predictors of Efficacy in the Radiofrequency Ablation of 100 Pathologically Proven Renal Cell Carcinomas. Journal of Vascular and Interventional Radiology 2014; 25, Issue 11, 1682–1688
Survey of Current Status and Physician Opinion Regarding Ancillary Staffing for the IR Suite
Hristina Natcheva of Mount Sinai Beth Israel (New York, N.Y.) discusses her recent article on physician opinion regarding ancillary staffing for the IR suite with SIR Resident-in-training, Jerome Kao, JVIR media correspondent. Follow us on Twitter @JVIRMedia
Survey of Current Status and Physician Opinion Regarding Ancillary Staffing for the IR Suite. Journal of Vascular and Interventional Radiology 2014; 25:1777–1784.
Listen to Experts Talk About Research Presented During SIR 2014 in San Diego
Week of June 4, 2014
Dr. Haiyang Tao (Massachusetts General Hospital, Boston) discusses his abstract presented at SIR 2014 with JVIR Media Correspondent Nicole Zimmerman (SUNY Upstate Medical University, Syracuse, N.Y.).
Cone beam CT Venography vs. Cortisol Measurements to Confirm Selective Right Adrenal Vein Catheterization During Adrenal Vein Sampling: Does Anatomical Selectivity Correlate With Biochemical Selectivity Ratios? (mp3, 8.28mb, 09:02)
Ammar Sarwar (Beth Israel Deaconess Hospital, Boston) discusses his abstract presented at SIR 2014 with JVIR Media Correspondent Olaguoke Akinwande (University of Louisville, Kentucky).
Inferior vena Cava Stenting For Malignant Obstruction (mp3, 4.98mb, 05:26)
Dr. Daniel Sze (PI) Zlatko Devcic of Stanford University Medical Center, Stanford, California, discuss their abstract presented at SIR 2014 with JVIR Media Correspondent Sampson Kyere, M.D., Ph.D., (University of Maryland Medical Center Baltimore).
Benjamin Contrella (University of Virginia, Charlottesville) discusses his abstract presented at SIR 2014 JVIR Media Correspondent Nicole Zimmerman (SUNY Upstate Medical University, Syracuse, N.Y.).
Week of May 28, 2014
Dr. Alan Matsumoto (University of Virginia, Charlottesville) discusses his abstract presented at SIR 2014 with JVIR Media Correspondent Dr. Kyle Cooper (The Ohio State University, Columbus).
Principal investigator Dr. Aaron Fischman and Jaskirat Virk of Mount Sinai Medical Center New York, N.Y., discuss their abstract presented at SIR 2014 with JVIR Media Correspondent Sampson Kyere, Ph.D., University of Maryland Medical Center Baltimore.
Megan Long (University of Arkansas for Medical Sciences, Little Rock) discusses her abstract presented at SIR 2014 with JVIR Media Correspondent Nicole Zimmerman (SUNY Upstate Medical University, Syracuse, N.Y.).
Leigh Casadaban from the University of Illinois Hospital in Chicago, discusses her abstract presented at SIR 2014 with JVIR Media Correspondent Dr. Jerome Kao (University of Tennessee Medical Center, Knoxville).
Week of May 21, 2014
Dr. George Getrajdman (Memorial Sloan-Kettering Cancer Center, N.Y.) discusses his abstract presented at SIR 2014 with JVIR media correspondent Dr. Jerome Kao (University of Tennessee Medical Center, Knoxville)
Surrogate Markers of Embolization Endpoint During Hepatic Arterial Oncologic Interventions Using Anti-reflux Devices: Potential Role For Intraprocedural Hepatic Arterial Pressure Measurement (mp3, 6.51mb, 07:07)
Drs. Kazim Narsinh and Steven Rose (University of California, San Diego) discuss their abstract presented at SIR 2014 with JVIR media correspondent Dr. Jerome Kao (University of Tennessee Medical Center, Knoxville).
Nassir Rostambeigi (University of Minnesota, Minneapolis) discusses his abstract presented at SIR 2014 with JVIR Media Correspondent Dr. Kyle Cooper (The Ohio State University, Columbus).
Microwave Ablation For Lung Neoplasms: A Retrospective Analysis of Long Term Results (mp3, 5.12mb, 05:36)
Dr. Bradford March (Rhode Island Hospital, Providence) discusses his abstract presented at SIR 2014 with JVIR Media Correspondent Olaguoke Akinwande (University of Louisville, Kentucky).
Week of May 14, 2014
Danny Chan (University of Toronto, Toronto, Canada) discusses his recent abstract on assessing the efficacy, complications, and re-intervention incidence following uterine fibroid embolization in patients with large fibroids with Nicole Zimmerman (SUNY Upstate Medical University, Syracuse, NY), JVIR Media Correspondent
Dr. Julius Chapiro (The Johns Hopkins Hospital, Baltimore) discusses his recent abstract on quantitative semi-Automatic 3D assessment of uterine fibroids after intra-arterial embolization – a feasibility study with Nicole Zimmerman (SUNY Upstate Medical University, Syracuse, New York), JVIR Media Correspondent
24-month final results from the RENOVA study: a randomized controlled comparison of stent grafts and balloon angioplasty for dialysis access graft preservation (mp3, 8.95mb, 09:46)
Dr. Ziv Haskal (University of Virginia, Charlottesville, Virginia) discusses his recent abstract on the final data from the RENOVA trial regarding angioplasty vs stenting for the treatment of stenoses in dialysis fistula with Dr. Kyle Cooper (The Ohio State University, Columbus, Ohio), JVIR Media Correspondent
Drs. Almamoon Justaniah and Shams Iqbal from Lahey Clinic in Burlington, MA discuss their recent abstract on the influence of bead size on tumor response rate after TACE in HCC with Dr. Jerome Kao from the University of Tennessee Medical Center in Knoxville, TN, JVIR media correspondent
Video: SIR 2014 Leaders in Innovation Award
Watch an Excerpt from Ziv Haskal, MD, FSIR's Acceptance Speech: What Specialty in Medicine Has Done So Much in So Many Areas For So Many?
With Flip of Wrist, Interventional Radiologists Treat Uterine Fibroids; Journal of Vascular and Interventional Radiology Report Highlights Benefits of Different Access Approach to Treat Women’s Noncancerous Growths; Could Be “Game Changer” for Image-guided Minimally Invasive Treatments, Improving Patient Comfort
SIR Foundation, Journal of Vascular and Interventional Radiology Present Awards; JVIR Editor’s Award for Outstanding Clinical Research Paper on Lens Opacities in Catheterization Personnel Presented to International Authority on Radiation Protection; Outstanding Laboratory Investigation Article Examines Therapies That Help Chemotherapy Patients
Interventional Radiologists Receive Honors From SIR Foundation; Ziv J Haskal, Journal of Vascular and Interventional Radiology Editor-in-chief, Will Receive Leaders in Innovation Award; Foundation Also Bestows Young Investigator, Research and Philanthropy Awards During SIR 2014
Medical Societies Unite on Patient-centered Measures for Non-surgical Stroke Interventions; Society of Interventional Radiology Publishes Guidelines That Capture Consensus on Clinical Practice of Intra-arterial Stroke Revascularization, Recommend National Stroke Outcomes Registry
Journal of Vascular and Interventional Radiology: There's an App for That: Society of Interventional Radiology's Flagship Publication Delivers Research Fast
Not Equal: Quality of Care, Cost for PAD Sufferers: Study of More Than 14,000 Medicare Patients With Peripheral Arterial Disease Helps Consumers Navigate Medical Provider and Treatment Choice
Join JVIR's International Community
JVIR International Affiliate Program
In July 2009, JVIR launched the International Affiliate Program that allows nonmembers of SIR who live outside of the United States, Canada and Mexico to purchase online-only access to the journal. JVIR is also a participant in the HINARI program, which provides discounted journal subscriptions to institutions in developing countries.
Standards and Position Statements
The Society of Interventional Radiology, with the support of 41 international societies representing 10,000 interventional radiology doctors, has issued the first global statement defining interventional radiology-one designed to benefit medical treatment for individuals. The statement addresses the evolution, impact and future direction of this minimally invasive specialty, emphasizing the worldwide availability of this specialized medical care. The statement, the result of more than two years of collaborative work, is being co-published in August as a "Special Communications" in SIR's Journal of Vascular and Interventional Radiology and in the Cardiovascular and Interventional Radiological Society of Europe's journal.
Society of Interventional Radiology Advances Global Definition of Specialty, Benefits Patients: A First: 41 Interventional Radiology Societies Join SIR in Supporting Statement That Stresses Interventional Radiology's Importance in Medical Care for Patients, Outlines Identity and Scope of IR Practices Worldwide, July 7, 2010
Global Statement Defining Interventional Radiology, "Special Communications," Journal of Vascular and Interventional Radiology, in print August 2010
"We Are IR," Journal of Vascular and Interventional Radiology, in print August 2010
Related JVIR Articles
Denied in Canada: Why We Need a Global Strategic Plan for Interventional Radiology, Journal of Vascular and Interventional Radiology, January 2008
Interventional Radiology Deserves Formal Recognition as a Distinct Medical Subspecialty: A Statement From the Canadian Interventional Radiology Association, Journal of Vascular and Interventional Radiology, January 2008
JVIR and ISET
JVIR has been named the official journal of ISET (International Symposium on Endovascular Therapy).
JVIR Endorses CONSORT Statement
JVIR endorses the CONSORT (Consolidated Standards of Reporting Trials) Statement. The CONSORT Statement contains criteria developed to improve the quality of published reports of randomized clinical trials. The current criteria consist of a 22-item checklist that pertains to the various sections of a report of a clinical trial (Title, Abstract, Introduction, Materials and Methods, Results, Discussion).
Beginning Oct. 1, when submitting a manuscript reporting a randomized controlled trial, authors are strongly encouraged to upload the CONSORT criteria checklist and flow diagram and to attach the completed checklist to their submission. These elements will not be mandatory initially. For more information on the CONSORT Statement and templates for the checklist and flowchart diagram, please visit www.consort-statement.org/home.
Top Subscription Benefits
JVIR publishes 12 issues a year as well as several topical supplements. SIR members receive a subscription to the journal and all supplements as a key benefit of SIR membership. Other features include:
- SIR Members Receive Monthly TOC Alerts from the Journal of Vascular and Interventional Radiology (JVIR). Members will receive an email previewing the selections for the upcoming issue of JVIR. Readers will be able to access article abstracts and, as a SIR member benefit, be able to view full text versions immediately, often ahead of print. Click here to preview this month's table of contents.
- Seamless access to the full text of JVIR Online. To personalize searches, once on JVIR.org, register in the upper left-hand corner.
- Instant access to complete journal content in the JVIR iPad® app upon registration on JVIR.org.
- All journal archives, dating back to JVIR's inception in 1990, are now available on JVIR Online. Online access and search tools are free with subscription.
- JVIR publishes articles online as soon as they have undergone production as Articles in Press, allowing papers to be available to researchers and clinicians quickly.
- Each issue of JVIR includes an article approved for continuing medical education (CME) credit.
- JVIR publishes SIRs Reporting Standards documents. These documents are freely available to the public.
- JVIR releases several supplements each year. In 2009, this included a collection of the most up-to-date Standards Division Guidelines.
- Subscribers have access to special e-collections produced by the journal, the first of which focuses on Uterine Artery Embolization.
- Through its publisher, JVIR is compliant with NIH funding mandates for providing articles to a centralized database.